Skip to main content
Livermore
Livermore
ZHEN

DCF Advisers, LLC

SEC CIK
0001802493
Latest filing
Aug 10, 2026

ALT holding history

Altimmune, Inc. in every 13F filed by DCF Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALT overviewAll 13F holders of ALTFull Q2 2026 holdings

Shares (Q2 2026)
14,700
Value
$44.7K
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of ALT by DCF Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,700$44.7K<0.1%00.0%UnchangedHolders
Q1 202614,700$45.3K<0.1%−4,000−21.4%ReducedHolders
Q4 202518,700$67.5K<0.1%+7,930+73.6%AddedHolders
Q3 202510,770$40.6K<0.1%00.0%UnchangedHolders
Q2 202510,770$41.7K<0.1%−11,000−50.5%ReducedHolders
Q1 202521,770$108.8K0.1%−47,098−68.4%ReducedHolders
Q4 202468,868$496.5K0.3%+31,000+81.9%AddedHolders
Q3 202437,868$232.5K0.1%−5,000−11.7%ReducedHolders
Q2 202442,868$285.1K0.1%−53,357−55.5%ReducedHolders
Q1 202496,225$979.6K0.6%−19,000−16.5%ReducedHolders
Q4 2023115,225$1.30M0.9%−4,750−4.0%ReducedHolders
Q3 2023119,975$311.9K0.2%00.0%UnchangedHolders
Q2 2023119,975$423.5K0.3%+43,000+55.9%AddedHolders
Q1 202376,975$324.8K0.2%−3,705−4.6%ReducedHolders
Q4 202280,680$1.33M1.0%−148,320−64.8%ReducedHolders
Q3 2022229,000$2.92M2.2%−106,180−31.7%ReducedHolders
Q2 2022335,180$3.92M2.6%+19,180+6.1%AddedHolders
Q1 2022316,000$1.92M1.1%+35,300+12.6%AddedHolders
Q4 2021280,700$2.57M1.3%+41,500+17.3%AddedHolders
Q3 2021239,200$2.71M1.5%+93,450+64.1%AddedHolders
Q2 2021145,750$1.44M0.7%+145,750NewHolders